Your browser doesn't support javascript.
loading
Health Care Provider Perceptions of Facilitators and Barriers to Human Papillomavirus Vaccination Delivery in Five Countries.
Islam, Jessica Y; Gurbani, Arshya; Ramos, Silvina; Morgan, Karen; Kim, Chan Joo; Richter, Karin L; de Sanjose, Silvia; Smith, Jennifer S; Vielot, Nadja A.
Afiliação
  • Gurbani A; Interdisciplinary Health Communication Program, School of Media and Journalism, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Ramos S; Centro de Estudios de Estado y Sociedad, Buenos Aires, Argentina.
  • Morgan K; Perdana University-Royal College of Surgeons in Ireland School of Medicine, Kuala Lumpur, Malaysia.
  • Kim CJ; Department of Obstetrics and Gynecology, The Catholic University of Korea College of Medicine, St Paul's Hospital, Seoul, Korea.
  • Richter KL; Department of Medical Virology, University of Pretoria, National Health Laboratory Service, Pretoria, South Africa.
  • de Sanjose S; PATH, Seattle, US & CIBER Epidemiologia y Salud Publica, Barcelona, Spain.
  • Vielot NA; Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Sex Transm Dis ; 48(8): 557-564, 2021 08 01.
Article em En | MEDLINE | ID: mdl-34014055
ABSTRACT

BACKGROUND:

National human papillomavirus (HPV) vaccination programs could reduce global cervical cancer morbidity and mortality with support from health care providers. We assessed providers' perceptions of HPV vaccination in 5 countries.

METHODS:

We identified providers from 5 countries where national HPV vaccination programs were at various stages of implementation Argentina, Malaysia, South Africa, South Korea, and Spain. Providers authorized to administer adolescent vaccines completed an in-depth survey, reporting perceptions of barriers and facilitators to initiating and completing HPV vaccination, and logistical challenges to HPV vaccination.

RESULTS:

Among 151 providers, common barriers to HPV vaccination initiation across all countries were parents' lack of awareness (39%), concerns about vaccine safety or efficacy (33%), and cost to patients (30%). Vaccination education campaign (70%) was the most commonly cited facilitator of HPV vaccination initiation. Common barriers to series completion included no reminder system or dosing schedule (37%), loss to follow-up or forgetting appointment (29%), and cost to patients (25%). Cited facilitators to completing the vaccine series were education campaigns (45%), affordable vaccination (32%), and reminder/recall systems (22%). Among all countries, high cost of vaccination was the most common logistical challenge to offering vaccination to adolescents (33%).

CONCLUSIONS:

Incorporating provider insights into future HPV vaccination programs could accelerate vaccine delivery to increase HPV vaccination rates globally.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Alphapapillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Qualitative_research Limite: Adolescent / Female / Humans País/Região como assunto: Africa / America do sul / Argentina / Asia / Europa Idioma: En Revista: Sex Transm Dis Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Alphapapillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Qualitative_research Limite: Adolescent / Female / Humans País/Região como assunto: Africa / America do sul / Argentina / Asia / Europa Idioma: En Revista: Sex Transm Dis Ano de publicação: 2021 Tipo de documento: Article